Clinical research at the Ulm site

The special interest of clinical research at the Ulm site is amyotrophic lateral sclerosis (ALS), frontotemporal lobar degenerations (FTLD) and Chorea Huntington's disease. The development of new diagnostic and therapeutic procedures is to be accelerated so that patients can benefit from them. In addition, new formats for clinical studies are being developed. The methodological fields of expertise of the Ulm site of the DZNE are imaging, blood and cerebrospinal fluid biomarkers and innovative formats for clinical trials.

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: